Tuesday, June 14, 2022 3:24:14 PM
I've been told you're wrong about this by an old fashioned stock broker years ago. He assured me that interested Institutions will buy in at the beginning of a quarter and will be out at the end unless the stock reaches their minimum. As long as they don't hold over the quarter they need not report the specific holdings. All such holding by them over the quarter are just lumped together and shown as a gain, or loss, in the quarter without specifying any of the stocks held during the quarter.
Also, there are Institutions that do have lower than $5 minimums. I should add that some Institutions don't officially invest in OTC regardless of the price, it doesn't mean they won't invest, they just won't hold them over the quarter, so they need not report it. Again, the hope is always that before the end of the quarter the company is on a major exchange.
No doubt DI is hearing that certain Institutions will be in once $5 has been hit, they'd be violating their charter to tell DI they'll be in before. The reality is that if they're watching the company now, and they'll be in when they choose to be. Some may wait for $5, or even for a move to a major exchange, but some could be in now, or in the very near future if they're waiting to see the Journal, or perhaps hear that we've filed with the regulators. They won't admit they're in, but the will be, but they'll be out by the last day of the quarter, and they'll not report it.
Gary
Also, there are Institutions that do have lower than $5 minimums. I should add that some Institutions don't officially invest in OTC regardless of the price, it doesn't mean they won't invest, they just won't hold them over the quarter, so they need not report it. Again, the hope is always that before the end of the quarter the company is on a major exchange.
No doubt DI is hearing that certain Institutions will be in once $5 has been hit, they'd be violating their charter to tell DI they'll be in before. The reality is that if they're watching the company now, and they'll be in when they choose to be. Some may wait for $5, or even for a move to a major exchange, but some could be in now, or in the very near future if they're waiting to see the Journal, or perhaps hear that we've filed with the regulators. They won't admit they're in, but the will be, but they'll be out by the last day of the quarter, and they'll not report it.
Gary
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
